At the same time, Alzheimer's disease polygenic risk scores (AD-PRS) can capture non-<i>APOE</i> common-variant burden across lipid transport, endosomal trafficking, innate immune signaling, complement activity, microglial regulation, mitochondrial stress, and neurovascular integrity. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.